These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2141150)

  • 1. [Pseudomonas infection in mucoviscidosis. Therapeutic strategies].
    Foucaud P; Bingen E; Lambert-Zechovsky N; Navarro J
    Presse Med; 1990 May; 19(21):983-5. PubMed ID: 2141150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacterial infections of the lungs in mucoviscidosis patients].
    Hogardt M; Heesemann J
    MMW Fortschr Med; 2005 Jan; 147(4):38-40. PubMed ID: 15745340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients.
    Rao P; McCaughan J; McCalmont M; Goldsmith CE; Hall V; Millar BC; McCann MA; Downey DG; Rendall JC; Elborn JS; Moore JE
    J Cyst Fibros; 2012 Jul; 11(4):349-52. PubMed ID: 22325689
    [No Abstract]   [Full Text] [Related]  

  • 4. Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis.
    Ali H; Orchard C; Mariveles M; Scott S; Alshafi K; Bilton D; Simmonds N
    Eur Respir J; 2015 Sep; 46(3):862-5. PubMed ID: 25882803
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of a Reduction in Susceptibility Testing for
    Ponce MC; Svendsen E; Steed L; Flume PA
    Am J Respir Crit Care Med; 2020 Jan; 201(1):114-116. PubMed ID: 31469583
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary exacerbations in cystic fibrosis: it's time to be explicit!
    Marshall BC
    Am J Respir Crit Care Med; 2004 Apr; 169(7):781-2. PubMed ID: 15044219
    [No Abstract]   [Full Text] [Related]  

  • 7. Eradication of early Pseudomonas infection in cystic fibrosis.
    Lee TW
    Chron Respir Dis; 2009; 6(2):99-107. PubMed ID: 19411571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered.
    Jones AM
    Eur Respir J; 2005 Sep; 26(3):373-5. PubMed ID: 16135714
    [No Abstract]   [Full Text] [Related]  

  • 9. Early detection of infection with Pseudomonas aeruginosa in cystic fibrosis: the Holy Grail or an achievable goal?
    Taccetti G; Sly PD
    J Cyst Fibros; 2014 Sep; 13(5):491-3. PubMed ID: 25156429
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Bozkurt-Güzel C; Gerçeker AA
    J Antibiot (Tokyo); 2012 Feb; 65(2):83-6. PubMed ID: 22126897
    [No Abstract]   [Full Text] [Related]  

  • 12. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D; Desmazes-Dufeu N; Dusser D
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract]   [Full Text] [Related]  

  • 13. Budget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients.
    Woodward TC; Brown R; Sacco P; Zhang J
    J Med Econ; 2010; 13(3):492-9. PubMed ID: 20670159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudomonas aeruginosa and mucoviscidosis].
    Lenoir G
    Rev Pneumol Clin; 1995; 51(3):151-9. PubMed ID: 7569577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
    Kernen Y; Sauty A; Roulet M
    Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
    Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
    J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.
    Pastor M; Moreno-Sastre M; Esquisabel A; Sans E; Viñas M; Bachiller D; Asensio VJ; Pozo AD; Gainza E; Pedraz JL
    Int J Pharm; 2014 Dec; 477(1-2):485-94. PubMed ID: 25445528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
    Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
    Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primum non nocere.
    Jaksic M; Vyas J
    Respirology; 2016 Feb; 21(2):205-6. PubMed ID: 26775616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.